Drugs / SWA1211
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07363967 | Jun 2025 → Sep 2027 expected | — | Beijing StoneWise Technology Co., Ltd | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SWA1211 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07363967 ↗ |
| Route | Oral | “Planned doses administered orally as a tablet daily” NCT07363967 ↗ |